Section 13.1: Negative Pressure Wound Therapy (NPWT)
Key Takeaways
- Negative Pressure Wound Therapy (NPWT) exerts five core biophysical mechanisms: macrostrain (wound contraction), microstrain (microscopic cellular stretch), fluid evacuation, edema reduction, and perfusion enhancement.
- Standard negative pressure is -125 mmHg continuous; lower pressure settings (-75 to -100 mmHg) are indicated for compromised arterial blood flow, friable tissue, or severe pain.
- Reticulated open-cell polyurethane foam (black foam) is hydrophobic and stimulates robust granulation, whereas polyvinyl alcohol foam (white foam) is hydrophilic, non-adherent, and protects exposed bone, tendon, or nerves.
- Key indications include dehisced surgical wounds, Stage 3 and 4 pressure injuries, diabetic foot ulcers, open traumatic wounds, and split-thickness skin graft (STSG) bolster fixation.
- Absolute contraindications to NPWT include >20% necrotic tissue/eschar, untreated osteomyelitis, exposed blood vessels or visceral organs, non-enteric or unexplored fistulas, and active malignancy in the wound bed.
Section 13.1: Negative Pressure Wound Therapy (NPWT)
Negative Pressure Wound Therapy (NPWT), also referred to as vacuum-assisted closure (VAC), represents one of the most significant technological advancements in advanced wound management over the past three decades. NPWT utilizes a sealed wound dressing system connected to a controlled vacuum pump to deliver subatmospheric pressure continuously or intermittently to the wound bed. By creating a closed, moist, subatmospheric environment, NPWT exerts unique biophysical forces that fundamentally alter the microenvironment of chronic and complex acute wounds, accelerating tissue repair and preparing the wound bed for definitive closure or surgical coverage.
Biophysical Mechanisms of Action
The therapeutic efficacy of NPWT is mediated through five primary biophysical mechanisms: macrostrain, microstrain, fluid evacuation, edema reduction, and perfusion enhancement. Understanding these mechanisms is essential for the Certified Wound Specialist (CWS) to optimize therapy parameters and troubleshoot non-healing wounds.
1. Macrostrain (Wound Contraction)
Macrostrain refers to the visible, physical deformation and contraction of the wound bed that occurs when subatmospheric pressure is applied to the polyurethane or polyvinyl alcohol foam manifold. As the vacuum collapses the open-cell foam structure, equal suction forces are transmitted across all contact surfaces of the wound. This results in:
- Approximation of Wound Margins: Drawing the wound edges inward toward the center, significantly reducing total wound surface area and volume.
- Reduction of Mechanical Tension: Decreasing lateral tissue tension at the wound perimeter, which facilitates cell migration and re-epithelialization.
- Dead Space Elimination: Removing anatomical gaps and cavities in deep or dehisced wounds, preventing fluid accumulation and abscess formation.
2. Microstrain (Microscopic Cell Stretch & Mechanotransduction)
Microstrain operates at the microscopic interface between the porous foam strut and the exposed wound bed cells. Under suction, micro-deformations occur where individual cell membranes are pulled into the pores of the foam. This micro-mechanical stretch triggers intracellular signaling cascades via mechanotransduction:
- Activation of Focal Adhesions & Integrins: Cell stretch activates transmembrane integrin receptors, triggering downstream intracellular phosphorylation pathways (e.g., FAK, ERK/MAPK pathways).
- Stimulation of Cellular Proliferation & Mitosis: Mechanically stretched fibroblasts, endothelial cells, and keratinocytes show marked upregulation of DNA synthesis and mitotic activity.
- Upregulation of Growth Factors: Increased localized secretion of Vascular Endothelial Growth Factor (VEGF), Fibroblast Growth Factor-2 (FGF-2), and Platelet-Derived Growth Factor (PDGF).
- Rapid Granulation Tissue Formation: Accelerated deposition of extracellular matrix (ECM) and sprouting of dense, robust capillary networks (angiogenesis).
3. Fluid Evacuation & Exudate Removal
Chronic wounds frequently exhibit excessive, toxic exudate laden with matrix metalloproteinases (MMPs), inflammatory cytokines (TNF-alpha, IL-1beta), and cellular debris that degrade extracellular matrix proteins and inhibit growth factor activity. NPWT continuously evacuates this fluid into a sealed canister, providing:
- Biochemical Clearance: Removal of inhibitory proteases and pro-inflammatory cytokines, transitioning the wound bed from a chronic inflammatory state to a proliferative state.
- Maceration Prevention: Protecting periwound skin from moisture-associated damage and breakdown.
- Bioburden Suppression: Continuous removal of non-adherent bacteria and exudate nutrients required for bacterial multiplication.
4. Edema Reduction & Microvascular Perfusion
Excessive interstitial fluid builds up in the extracellular space surrounding acute and chronic wounds, generating high interstitial hydrostatic pressure. This elevated pressure compresses local capillaries and venules, compromising microvascular blood flow and producing local tissue hypoxia.
- Decompression of Capillary Beds: By draining interstitial fluid, NPWT lowers interstitial pressure, un-collapsing microvessels.
- Restoration of Perfusion & Oxygenation: Enhanced microvascular blood flow improves delivery of oxygen, systemic nutrients, and systemic antibiotics to the wound bed.
- Reduction of Lymphatic Congestion: Facilitates lymphatic drainage in chronic venous or dependent extremity edema.
Operational Parameters & Pressure Settings
Optimal NPWT outcomes depend on tailoring pressure levels, delivery modes, and dressing change frequency to the specific clinical presentation of the wound.
Negative Pressure Levels
- Standard Setting (-125 mmHg): The landmark clinical trials established -125 mmHg continuous negative pressure as the optimal baseline setting for maximizing microvascular blood flow and granulation tissue formation in reticulated polyurethane foam dressings.
- Reduced Pressure Settings (-75 mmHg to -100 mmHg): Indicated for patients with significant pain, delicate or friable tissue, compromised arterial perfusion (e.g., peripheral artery disease with ABI 0.6–0.8), elderly patients with skin tears, or when using dense polyvinyl alcohol (PVA) foam.
- Elevated Pressure Settings (-150 mmHg to -175 mmHg): Occasionally utilized for extremely large, highly exudative wounds, open abdominal wounds, or heavy surgical dehiscence requiring maximal fluid evacuation.
Pressure Delivery Modes
- Continuous Mode: Subatmospheric pressure is applied constantly without interruption. Indicated for the initial 48 hours of therapy, highly exudative wounds, painful wounds, unstable wound beds, sinus tracts, and split-thickness skin graft fixation. Continuous mode minimizes painful movement of foam inside the wound.
- Intermittent Mode (-125 mmHg ON / 0 mmHg OFF): Pressure cycles between active suction (typically 5 minutes) and atmospheric pressure (typically 2 minutes). Intermittent pressure stimulates significantly higher rates of granulation tissue formation compared to continuous mode due to repeated cycles of cellular stretch and relaxation. However, it is poorly tolerated by many patients due to discomfort during suction cycling.
- Variable / Dynamic Mode: Smoothly transitions negative pressure between two subatmospheric levels (e.g., -125 mmHg and -25 mmHg) without dropping to zero. Provides the cellular stimulation of intermittent therapy while avoiding the pain associated with complete loss of foam compression.
Dressing Interfaces & Foam Material Selection
The choice of wound contact material determines the nature of tissue interaction, granulation density, and pain during dressing changes.
| Interface Material | Physical Characteristics | Primary Indications | Clinical Precautions |
|---|---|---|---|
| Reticulated Open-Cell Foam (Black Polyurethane Foam) | Hydrophobic, pore size 400–600 µm, high tensile strength, highly flexible | Standard wounds, Stage 3/4 pressure injuries, DFUs, dehisced surgical wounds, STSG fixation | Avoid direct contact with exposed blood vessels, nerves, or tendons; high tissue ingrowth risk if left >72 hrs |
| Polyvinyl Alcohol Foam (White PVA Foam) | Hydrophilic, dense, small pore size, non-adherent, moist, high density | Exposed bone, tendon, or nerves; narrow sinus tracts/tunnels; painful wound beds; protection of deep structures | Requires higher suction pressure (-125 to -150 mmHg) due to high resistance of dense foam structure |
| Silver-Infused Polyurethane Foam | Reticulated black foam impregnated with ionic silver | Wounds with high bioburden or localized/critically colonized infection | Limit use to 14 days unless clinical re-evaluation confirms persistent bioburden; monitor for silver sensitivity |
| Non-Adherent Contact Layer (e.g., Silicone / Petrolatum Mesh) | Porous, non-adherent barrier placed directly over wound bed prior to foam | Placed beneath black foam over fragile structures, exposed tendons, or meshed skin grafts | Must be fenestrated or porous to allow unimpeded suction and exudate evacuation through to the foam manifold |
Clinical Indications & Application Protocols
NPWT is indicated across a broad spectrum of acute, subacute, and chronic wounds:
- Dehisced Surgical Incisions: Rapidly clears exudate, contracts gaping surgical margins, and fills deep dead space.
- Pressure Injuries (Stage 3 and Stage 4): Promotes granulation tissue over deep fascia, muscle, or exposed bony prominences following appropriate surgical or conservative debridement.
- Diabetic Foot Ulcers (DFUs): Indicated for post-debridement neuropathic foot ulcers (Wagner Grade 2 and 3) to fill tissue deficits prior to secondary closure or grafting.
- Split-Thickness Skin Graft (STSG) Fixation: Serves as a uniform bolster dressing, securing the graft to the recipient bed, eliminating seromas/hematomas, and promoting rapid graft revascularization (typically left intact for 3–5 days).
- Traumatic Wounds & Flaps: Manages high-energy soft tissue loss, open fractures (Gustilo Grade II/III), and secures pedicle or free tissue transfers.
Absolute and Relative Contraindications
Applying NPWT in the presence of absolute contraindications can lead to catastrophic complications, including fatal hemorrhage, severe sepsis, or accelerated tumor growth.
| Category | Clinical Entity | Pathophysiological Danger / Rationale |
|---|---|---|
| Absolute Contraindication | Necrotic Tissue / Eschar | Eschar (>20% wound bed cover) acts as a physical barrier preventing suction transmission; NPWT over necrotic tissue breeds severe anaerobic infection. Must fully debride first. |
| Absolute Contraindication | Untreated Osteomyelitis | Applying NPWT over infected, non-debrided bone traps bacterial pathogens under a sealed dome, precipitating systemic sepsis. Bone must be debrided/treated first. |
| Absolute Contraindication | Exposed Major Blood Vessels / Organs | Suction and foam erosion into major arteries (e.g., femoral artery), veins, or visceral organs causes catastrophic, life-threatening hemorrhage or bowel perforation. |
| Absolute Contraindication | Non-Enteric / Unexplored Fistulas | Negative pressure over unexplored or non-enteric fistulas can enlarge the fistula tract, cause gut evisceration, or draw massive GI fluids into the canister. |
| Absolute Contraindication | Active Malignancy in Wound Bed | Macrostrain and microstrain stimulate cellular mitosis and angiogenesis, accelerating localized tumor growth and metastatic dissemination. |
| Relative Precaution | Active Bleeding / Anticoagulation | High risk of hemorrhage; requires low pressure (-75 mmHg), non-adherent contact layer, and strict monitoring. |
Clinical Case Vignette
Clinical Scenario: A 58-year-old male with type 2 diabetes mellitus presents following surgical debridement of a left plantar diabetic foot ulcer. Post-debridement examination reveals a clean, red wound bed measuring 4.5 cm × 3.0 cm × 1.2 cm with exposed flexor tendon in the base. No necrotic tissue or osteomyelitis is present. The wound care specialist selects NPWT.
Clinical Decision-Making: Because flexor tendon is exposed in the wound base, applying reticulated open-cell black foam directly over the tendon poses a high risk of tendon desiccation and tissue ingrowth, which can cause tendon rupture during dressing changes. The clinician correctly applies a non-adherent porous silicone contact layer (or white PVA foam) directly over the exposed tendon, followed by black polyurethane foam to fill the remainder of the wound deficit. Negative pressure is initiated at -125 mmHg continuous mode.
A wound specialist is treating a Stage 4 ischial pressure injury with NPWT. During a dressing change, the clinician notes exposed cortical bone at the base without necrotic tissue or active infection. Which interface dressing setup is most appropriate?
Which set of clinical findings represents an ABSOLUTE contraindication to initiating Negative Pressure Wound Therapy?
What is the primary biophysical distinction between macrostrain and microstrain mechanisms in NPWT?